STOCK TITAN

Airgain, Inc. Form 4 Filings

AIRG NASDAQ

Every Form 4 that Airgain, Inc. (AIRG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow AIRG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AIRG filings page.

Rhea-AI Summary

Airgain Inc. director Stephan D. Memmen purchased 1,500 shares of common stock on October 2, 2026, at a weighted average price of $4.55 per share; individual purchase prices ranged from $4.43 to $4.61. No Rule 10b5-1 plan is reported.

The October 1 awards included 9,508 restricted stock units and options to buy 21,127 shares at an exercise price of $4.25 per share. Both awards vest in substantially equal installments on each of the first three anniversaries of grant, subject to continued board service.

Rhea-AI Summary

AIRGAIN INC (AIRG) president and CEO, and director, Jacob Suen sold 1,000 shares of common stock on September 3, 2026 at $5.20 per share in an open-market transaction pursuant to a Rule 10b5-1 trading plan. After this sale, he holds 279,431 shares directly, including restricted stock units.

Rhea-AI Summary

AIRGAIN INC (AIRG) director James K. Sims reported open-market purchases of the company’s Common Stock across two days. On August 31, 2026, he purchased 6,731 shares at a weighted average price of $5.31 per share, in multiple trades between $5.12 and $5.40. On September 1, 2026, he purchased 8,269 shares at a weighted average price of $5.11 per share, in multiple trades between $4.98 and $5.25. In total, the Form 4 reports net purchases of 15,000 shares of AIRGAIN INC Common Stock held directly, and the reported holdings include restricted stock units.

Rhea-AI Summary

Airgain Inc director Arthur M. Toscanini exercised a fully vested stock option for 7,832 shares of common stock at an exercise price of $1.90 per share on May 19, 2026. The option position was reduced to zero, and his direct common stock holdings increased to 120,824 shares, which include restricted stock units.

Rhea-AI Summary

Airgain Inc. director James K. Sims exercised stock options covering 9,510 shares of common stock on 2026-04-10 at an exercise price of $1.90 per share. The corresponding option, which was fully vested and exercisable, was eliminated for this amount.

Following the exercise, Sims directly holds 442,733 shares of Airgain common stock, a figure that includes restricted stock units.

Rhea-AI Summary

AIRGAIN INC President and CEO Jacob Suen reported a small open-market sale of company stock. On this Form 4, he sold 1,000 shares of Common Stock at an average price of $7.04 per share. After the sale, he directly holds 280,431 shares, a large remaining position.

The filing notes that the sale was carried out under a pre-established Rule 10b5-1 trading plan adopted on March 12, 2025, indicating the transaction was scheduled in advance. The reported holdings also include Restricted Stock Units, which are equity awards that can convert into common shares over time.

Rhea-AI Summary

Airgain Inc. President and CEO Jacob Suen reported an exercise-and-sell transaction involving company common stock. He exercised employee stock options for 4,573 shares at $1.9000 per share, from a grant received on May 24, 2016 under the 2013 Equity Incentive Plan that was approaching its May 2026 expiration.

The same day, he completed an open-market block trade selling 4,573 shares of common stock at a weighted-average price of $6.5107 per share. Following these transactions, Suen directly holds 281,431 shares of Airgain common stock. The reported stock option grant is now fully exercised with no remaining derivative position from this award.

Rhea-AI Summary

Airgain Inc.'s Chief Financial Officer Michael Elbaz reported open-market sales of company stock. On May 12 and May 13, he sold a total of 5,274 shares of Airgain common stock at weighted average prices of $6.9801 and $6.7677 per share, respectively. After these transactions, he directly owns 135,506 shares of common stock, a figure that includes Restricted Stock Units.

Rhea-AI Summary

Airgain Inc. President and CEO Jacob Suen reported an open-market sale of 1,000 shares of common stock at $7.03 per share. After this transaction, he directly holds 281,431 shares, including Restricted Stock Units. The sale was made under a Rule 10b5-1 trading plan established on March 12, 2025.

Rhea-AI Summary

AIRGAIN INC former CTO Ali Sadri sold 1000 shares of Common Stock in an open-market transaction. The sale on April 17, 2026 was executed at $6.2100 per share pursuant to a Rule 10b5-1 trading plan established on August 13, 2025. After the sale, he directly held 124263 shares, which include Restricted Stock Units.

Rhea-AI Summary

Airgain Inc. President and CEO Jacob Suen reported an open-market sale of 1,000 shares of common stock at $5.51 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan established on March 12, 2025. After the sale, he directly holds 282,431 shares, which includes Restricted Stock Units.

Rhea-AI Summary

Airgain Inc.'s Chief Financial Officer Michael Elbaz reported an automatic sale of 12,769 shares of common stock at a weighted average price of $4.1192 per share. The shares were sold to cover tax withholding obligations triggered by the vesting and settlement of restricted stock units.

The transaction was executed as a pre-arranged "sell to cover" block trade under an instruction letter intended to satisfy the affirmative defense conditions of Rule 10b5-1, meaning it was not a discretionary trade. After this sale, Elbaz directly holds 140,780 shares, which include RSUs.

Rhea-AI Summary

AIRGAIN INC President and CEO Jacob Suen reported open-market sales of 38,314 shares of Common Stock. He sold 37,314 shares at a weighted-average price of $4.1192 on March 20 and 1,000 shares at $5.00 on March 23. Footnotes explain that a portion of the shares were automatically sold to cover tax withholding tied to vesting restricted stock units through a “sell to cover” arrangement, and the transactions were executed under a pre-arranged Rule 10b5-1 trading plan. Following these sales, Suen directly holds 283,431 shares, a figure that includes RSUs.

Rhea-AI Summary

Airgain Inc.’s Chief Technology Officer Ali Sadri reported routine insider sales tied to tax withholding. He sold a total of 14,638 shares of common stock in open‑market transactions on March 20 and March 23, 2026, at prices between about $4.12 and $5.00 per share. The filing explains these sales were executed to cover tax obligations from vesting and settlement of restricted stock units through an automatic “sell to cover” arrangement, rather than discretionary trading. The transactions were carried out under a pre‑established Rule 10b5‑1 trading plan. After these sales, Sadri directly holds 125,263 shares of Airgain common stock, which the filing notes includes RSUs.

Rhea-AI Summary

AIRGAIN INC Chief Financial Officer Michael Elbaz reported equity compensation awards. He received a stock option for 60,447 shares of common stock at an exercise price of $4.02 per share, expiring on March 14, 2036. The option vests 25% on March 15, 2027, with the remainder vesting in equal monthly installments over the following three years, subject to continued service and potential acceleration under his employment agreement.

Elbaz also acquired 10,774 fully vested restricted stock units and 9,669 restricted stock units that vest in substantially equal installments on each of March 15, 2027, March 15, 2028, March 15, 2029, and March 15, 2030, also subject to continued service and possible acceleration. Following these grants, he directly holds 153,549 shares of common stock. These awards are compensation-related acquisitions, not open-market purchases or sales.

Rhea-AI Summary

Airgain Inc. Chief Technology Officer Ali Sadri reported equity compensation awards rather than open-market trades. He received a stock option for 43,656 shares of common stock at an exercise price of $4.02 per share, expiring in 2036, alongside new restricted stock unit grants.

The filing shows 11,116 restricted stock units that are fully vested and 6,983 restricted stock units scheduled to vest in substantially equal installments on March 15 of 2027, 2028, 2029, and 2030, subject to continued service and potential acceleration under his employment agreement.

After these awards, Sadri directly holds 139,901 shares of common stock and 43,656 option shares. These transactions are classified as grant or award acquisitions, reflecting compensation-related equity rather than discretionary buying or selling.

Rhea-AI Summary

Airgain Inc. President and CEO Jacob Suen reported equity compensation awards on this Form 4. He received a stock option covering 82,275 shares of common stock at an exercise price of $4.0200 per share, expiring on March 14, 2036, which vests 25% on March 15, 2027 and then in equal monthly installments thereafter, subject to continued service.

He was also granted restricted stock units representing 25,653 and 13,161 shares of common stock, described as grants/awards. Footnotes state that some restricted stock units are fully vested and others vest in substantially equal installments on each of March 15, 2027, March 15, 2028, March 15, 2029 and March 15, 2030, with potential acceleration under his employment agreement. Following these grants, Suen directly holds 321,745 shares of common stock.

Rhea-AI Summary

Airgain Inc Chief Technology Officer Ali Sadri reported an automatic sale of 1,228 shares of common stock at an average price of $4.1577 per share. The transaction was a “sell to cover” sale executed to satisfy tax withholding obligations upon vesting of restricted stock units, under a pre-existing Rule 10b5-1 instruction letter. After this non-discretionary sale, Sadri directly holds 121,802 shares, which include RSUs.

Rhea-AI Summary

AIRGAIN INC President and CEO Jacob Suen reported an open-market sale of 3,704 shares of common stock at an average price of $4.1577 per share. According to the disclosure, this sale was executed solely to cover tax withholding obligations from the vesting and settlement of restricted stock units through an automatic “sell-to-cover” instruction under Rule 10b5-1 and is not a discretionary trade. After this transaction, Suen directly owns 282,931 shares of AIRGAIN INC common stock, which includes RSUs.

Rhea-AI Summary

Airgain Inc.'s Chief Technology Officer Ali Sadri reported an open-market sale of 1,000 shares of common stock at a weighted average price of $5.2774 per share. The transactions on February 17, 2026 were executed under a pre-established Rule 10b5-1 trading plan.

The shares were sold in multiple trades at prices ranging from $5.0200 to $5.5200. After this sale, Sadri beneficially owns 123,030 shares of Airgain common stock, a figure that includes restricted stock units.

Rhea-AI Summary

Airgain President and CEO Jacob Suen reported open-market sales of the company’s common stock. On February 9, 2026, he sold 6,112 shares at a weighted average price of $5.0068 per share. On February 10, 2026, he sold another 888 shares at a weighted average price of $5.0745 per share.

The transactions were carried out under a pre-arranged Rule 10b5-1 trading plan established on March 12, 2025. Following these sales, Suen directly owned 286,635 shares of Airgain common stock, which the filing notes include restricted stock units.

Rhea-AI Summary

Airgain, Inc. Chief Technology Officer Sadri Ali reported small stock sales under a pre-set trading plan. On February 9, he sold 2,119 shares of common stock at a weighted average price of $5.0095 per share. On February 10, he sold 881 shares at a weighted average price of $5.2426 per share.

The filing notes these open-market sales were executed pursuant to a Rule 10b5-1 trading plan established on August 13, 2025. After the transactions, Ali directly beneficially owned 124,030 shares of Airgain common stock, a figure that includes restricted stock units.

Rhea-AI Summary

Airgain, Inc. director Arthur M. Toscanini reported equity awards in the form of restricted stock units (RSUs) and stock options. He acquired 7,257 shares of common stock on February 2, 2026, representing RSUs that each convert into one share, at a grant price of $0. Following this, he beneficially owned 112,992 shares of common stock, including RSUs. He was also granted a stock option for 12,660 shares at an exercise price of $4.27 per share, with all option shares and RSUs scheduled to vest 100% on February 2, 2027, subject to his continued service. The option expires on February 1, 2036, and all reported holdings are listed as directly owned.

Rhea-AI Summary

Airgain, Inc. director James K. Sims received new equity awards. On February 2, 2026, he was granted 10,885 restricted stock units with a grant price of $0. All of these RSUs vest on February 2, 2027, if he continues serving the company through that date.

He also received a stock option for 18,991 shares at an exercise price of $4.27 per share, vesting 100% on February 2, 2027 and expiring on February 1, 2036. After these awards, he directly holds 433,223 shares of common stock, which includes RSUs, and 18,991 stock options.

Rhea-AI Summary

Airgain, Inc. director Thomas A. Munro received new equity awards in the form of restricted stock units and stock options. On February 2, 2026, he was granted 7,257 shares of common stock as RSUs at a price of $0, bringing his directly held and RSU-included common stock holdings to 84,171 shares. He was also granted a stock option covering 12,660 shares at an exercise price of $4.27 per share, vesting 100% on February 2, 2027 and expiring on February 1, 2036, contingent on continued service.

Rhea-AI Summary

Airgain, Inc. director Joan H. Gillman received new equity awards as part of her compensation. On February 2, 2026, she was granted 7,257 shares of common stock in the form of restricted stock units at no cost, which all vest on February 2, 2027 if she continues serving the company.

She also received a stock option covering 12,660 shares of common stock with an exercise price of $4.27 per share, vesting 100% on February 2, 2027 and expiring on February 1, 2036. After these grants, she beneficially owns 43,991 shares of Airgain common stock, including RSUs, held directly.

Rhea-AI Summary

Airgain, Inc. director T J Chung received new equity awards in the form of restricted stock units and stock options. On February 2, 2026, Chung was granted 7,257 RSUs at a price of $0, which fully vest on February 2, 2027, if service continues. On the same date, Chung received a stock option for 12,660 shares at an exercise price of $4.27 per share, vesting 100% on February 2, 2027 and expiring on February 1, 2036. Following these grants, Chung directly beneficially owned 51,015 shares of common stock, including RSUs, and 12,660 stock options.

Rhea-AI Summary

Airgain, Inc. director Kiva A. Allgood reported new equity awards consisting of restricted stock units and stock options. On February 2, 2026, Allgood received 7,257 restricted stock units, each representing one share of common stock, at a grant price of $0, all vesting on February 2, 2027, subject to continued service.

On the same date, Allgood was also granted a stock option covering 12,660 shares of common stock at an exercise price of $4.27 per share. The option vests in full on February 2, 2027, contingent on continued service, and will be exercisable through February 1, 2036. Following these grants, Allgood directly beneficially owned 36,849 shares of common stock, including RSUs.

Rhea-AI Summary

Airgain, Inc. President and CEO Jacob Suen, who is also a director, reported an automatic sale of common stock linked to equity compensation. On January 20, 2026, he sold 15,993 shares of Airgain common stock at a weighted average price of $3.996 per share, with individual trade prices ranging from $3.9838 to $3.9966. The filing states that these shares were sold solely to cover tax withholding obligations arising from the vesting and settlement of restricted stock units through a pre-arranged "sell-to-cover" instruction.

The transaction is described as non-discretionary, executed under an instruction letter intended to meet the affirmative defense conditions of Rule 10b5-1. Following this sale, Suen beneficially owned 293,635 shares of Airgain common stock, a figure that includes restricted stock units.

Rhea-AI Summary

Airgain, Inc. Chief Technology Officer Sadri Ali reported an automatic sale of 4,733 shares of common stock on January 20, 2026 to cover tax withholding obligations. The shares were sold through a "sell-to-cover" transaction tied to the vesting and settlement of restricted stock units, described as a non-discretionary arrangement under an instruction letter intended to satisfy Rule 10b5-1 affirmative defense conditions.

The sale had a weighted average price of $3.9963 per share, with individual trades executed between $3.9900 and $3.9966. Following this tax-related sale, Ali beneficially owned 127,030 shares of Airgain common stock, which includes RSUs.

Rhea-AI Summary

Airgain, Inc. Chief Financial Officer Michael Elbaz reported an automatic sale of company stock tied to equity compensation. On January 20, 2026, he sold 4,587 shares of Airgain common stock at a weighted average price of $3.9961 per share. The filing explains that the sale was a "sell-to-cover" transaction to pay tax withholding obligations arising from the vesting and settlement of Restricted Stock Units, and is not a discretionary trade. Following this transaction, Elbaz beneficially owned 133,106 shares of Airgain common stock, including RSUs. The instruction for these automatic sales is intended to satisfy the affirmative defense conditions of Rule 10b5-1.

Rhea-AI Summary

Airgain, Inc. insider filing: The company’s President and CEO, who is also a director, reported the sale of 2,070 shares of Airgain common stock on 11/24/2025. The shares were sold at a weighted average price of $3.9895 per share, in multiple trades within a price range of $3.9818 to $4.1129.

The filing explains that this was a “sell to cover” transaction, where shares were automatically sold to cover tax withholding obligations arising from the vesting and settlement of restricted stock units (RSUs). It states that the transaction was not a discretionary trade by the executive and was carried out under an instruction letter intended to satisfy the affirmative defense conditions of Rule 10b5-1.

After this transaction, the reporting person beneficially owns 309,628 shares of Airgain common stock, which includes RSUs.

Rhea-AI Summary

Airgain, Inc. Chief Technology Officer reports small share sale to cover taxes. A company officer filed a Form 4 showing the sale of 976 shares of Airgain common stock on 11/24/2025 at a weighted average price of $3.9894 per share. After this transaction, the officer beneficially owns 131,763 shares, which include Restricted Stock Units (RSUs).

The filing explains that the sale was made solely to cover tax withholding obligations arising from the vesting and settlement of RSUs and is described as a non-discretionary “sell-to-cover” transaction. The officer has an instruction letter in place so these tax-related sales are executed automatically under a plan intended to meet the affirmative defense conditions of Rule 10b5-1.

Rhea-AI Summary

Airgain, Inc. (AIRG) Chief Financial Officer Michael Elbaz reported the sale of 4,820 shares of common stock on 11/24/2025. The shares were sold at a weighted average price of $3.9895 per share in multiple transactions between $3.9818 and $4.1168.

The filing explains that this was a “sell to cover” transaction to satisfy tax withholding obligations arising from the vesting and settlement of restricted stock units, and is not a discretionary trade. After this transaction, Elbaz beneficially owned 137,693 shares, which includes RSUs. The instruction letter for these automatic sales is intended to meet the affirmative defense conditions of Rule 10b5-1.